In recent years, in order to further accelerate the pace of development and development of the new product, the company strengthened its cooperation with internationally renowned pharmaceutical companies and research institutions. In 2012, it signed the technology authorization and cooperation agreement with Taiwan Taijing Biological Technology Co., Ltd. and Taijing Biomedical Research and Development (Beijing) Co., Ltd. and obtained the exclusive patent license of the 1.1 class innovation medicine fluorine-free quinolone "nemonoxacin" within the territory of China. Its oral ...


At present, Zhejiang Medicine Co. Ltd. is specialized in the large-scale production of fat-soluble vitamins, quasi-vitamins, quino-lone antibiotics, anti-drug-resistant antibiot- ics and other products. Its output of vitamin E is the largest domestically, and the 2nd largest globally; the output of Vancomycin hydrochloride accounts for more than 40% of the global production.

维京掠宝送彩金 2018cba季后赛半决赛比分 浙江快乐12 神秘深红 免费好友打麻将软件 今日陕西十一选五开 国标麻将胡牌番数要求 芝麻策略 河北十一选五万能码 竞彩比分500万 股票行情实时查询002027 江苏七位数开奖结果 奥迅球探比分直播 北京11选5开奖号 竞彩比分直播最快最准 甘肃十一选五 默友贵州麻将